• ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Average Rating of "Buy" by Analysts

    Source: Buzz FX / 28 Nov 2024 03:36:11   America/New_York


    ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Average Rating of "Buy" by Analysts Written by MarketBeat November 28, 2024 Share Link copied to clipboard. Shares of ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Get Free Report ) have received a
    Read more...
Share on,